摘要
目的:探讨重组胸腺素β4(Tβ4)对心肌梗死大鼠心微血管形成及血管内皮生长因子(VEGF)表达的影响.方法:SD大鼠随机分为对照组、低剂量Tβ4组(0.08μg/100g)和高剂量Tβ4组(0.8μg/100g),结扎大鼠左冠状动脉前降支,造成永久心肌梗死模型.对照组予PBS,低剂量组和高剂量组予Tβ4腹腔注射,1、5、10d在结扎线以下的部位取材,行碱性磷酸酶和VEGF免疫组织化学显色.结果:各组微血管面积、VEGF阳性细胞平均光密度(AOD)1d差异无统计学意义,给药组10d微血管密度高于对照组,高剂量组5、10d微血管密度高于低剂量组,高剂量组10dVEGF阳性细胞平均光密度高于对照组和低剂量组.结论:Tβ4能促进心肌梗死后微血管形成,增加心肌微血管密度,上调VEGF的表达,从而改善心功能.
Abstract Objective: To study the effects of recombinant thymosin β4 on microvascular generation and expression of vascular endothelial growth factor (VEG-F) after myocardial infarction in rats. Methods:Sprague Dawley rats were randomly divided into a sham group, low-dose (0. 08μg/100 g) and high-dose (0.8μg/100 g) treatment groups. A rat permanent myocardial infarc- tion model was established after tigating left anterior descending coronary artery; the sham group was received PBS treatment, and the treatment groups were received thymosin 134 injections intraperitoneal every day. At 1 day, 5 days and 10 days, the hearts were removed, and the alkaline phosphatase enzyme histochemistry and VEG-F immunohistochemistry were made. Results: There was no significant difference in the microvascular area and average optical density (AOD) of VEGF in each group at 1 day. AOD of VEGF in the 10 day treatment group was higher than that in the sham group, and the microvascular density of high-dose group was higher than that in the low-dose group at 5 and 10 days. The AOD of VEGF positive cells at 10 days of the high-dose group was higher than that of other groups. Conclusion: Our results demonstrate that thymosin β4 can improve cardiac function through promoting myocardial angiogenesis, upregulating expression of VEGF and increasing myocardial microvascular density.
出处
《解剖学杂志》
CAS
CSCD
北大核心
2010年第5期591-594,共4页
Chinese Journal of Anatomy
关键词
重组胸腺素β4
心肌梗死
微血管
血管内皮生长因子
thymosin 134
myocardial infarction
microvasculature
vascular eadothelial growth factor